Literature DB >> 19638003

Fungal biomass is a key factor affecting polymorphonuclear leucocyte-induced hyphal damage of filamentous fungi.

Charalampos Antachopoulos1, Joanne P Demchok, Emmanuel Roilides, Thomas J Walsh.   

Abstract

Previous studies have not systematically assessed the effect of fungal biomass on polymorphonuclear leucocyte (PMN)-induced hyphal damage (HD) of filamentous fungi. We hypothesised that fungal biomass is a significant factor affecting PMN-induced HD. One isolate each consisting of a volume of 2 x 10(4) conidia ml(-1) of Aspergillus fumigatus, Aspergillus flavus, Aspergillus terreus, Rhizopus oryzae, Rhizopus microsporus, Cunninghamella bertholletiae, Scedosporium prolificans and Fusarium solani were incubated for six different time periods yielding biomass values between 0.01 and 0.1 optical density (OD, 405 nm). Polymorphonuclear leucocyte were added at effector-target (E : T) ratios of 5 : 1, 10 : 1, 20 : 1, 50 : 1 and 100 : 1, and HD was assessed by XTT [2,3-bis-(2-methoxy-4-nitro-5-sulphophenyl)-2H-tetrazolium-5-carboxanilide] metabolic assay. Hyphal damage decreased with increasing biomass following the sigmoid (E(max)) model (median R(2): 0.87). Hyphal damage at 0.01 OD exceeded HD at 0.1 OD (P < 0.01) by >twofold in 64 out of 80 comparisons. The sigmoid curves were shifted to the right with higher E : T ratios; the EC(50) values (OD values showing HD halfway between maximal and minimal HD) obtained for 50 : 1 or 100 : 1 were higher than for 5 : 1 (P < 0.01). Using the same E : T ratio, interspecies differences were observed; for 5 : 1, lower EC(50) values were obtained for A. flavus and the zygomycete species. In conclusion, PMN-induced HD decreases with increasing biomass. This effect is both species-dependent and E : T ratio-dependent.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19638003      PMCID: PMC6999700          DOI: 10.1111/j.1439-0507.2009.01725.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  19 in total

1.  Use of spectrophotometric reading for in vitro antifungal susceptibility testing of Aspergillus spp.

Authors:  E Dannaoui; F Persat; M F Monier; E Borel; M A Piens; S Picot
Journal:  Can J Microbiol       Date:  1999-10       Impact factor: 2.419

Review 2.  Infections due to emerging and uncommon medically important fungal pathogens.

Authors:  T J Walsh; A Groll; J Hiemenz; R Fleming; E Roilides; E Anaissie
Journal:  Clin Microbiol Infect       Date:  2004-03       Impact factor: 8.067

3.  Invasive aspergillosis: current and future challenges in diagnosis and therapy.

Authors:  W W Hope; D W Denning
Journal:  Clin Microbiol Infect       Date:  2004-01       Impact factor: 8.067

4.  Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis [2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide], for antifungal susceptibility testing of Aspergillus species.

Authors:  J Meletiadis; J W Mouton; J F Meis; B A Bouman; P J Donnelly; P E Verweij
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

5.  Concentration-dependent synergy and antagonism within a triple antifungal drug combination against Aspergillus species: analysis by a new response surface model.

Authors:  Joseph Meletiadis; Theodouli Stergiopoulou; Elizabeth M O'Shaughnessy; Joanne Peter; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2007-03-26       Impact factor: 5.191

6.  Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens.

Authors:  J M Gaviria; J A van Burik; D C Dale; R K Root; W C Liles
Journal:  J Infect Dis       Date:  1999-04       Impact factor: 5.226

Review 7.  Immunity to fungal infections.

Authors:  Luigina Romani
Journal:  Nat Rev Immunol       Date:  2004-01       Impact factor: 53.106

8.  Damage to Aspergillus fumigatus and Rhizopus oryzae hyphae by oxidative and nonoxidative microbicidal products of human neutrophils in vitro.

Authors:  R D Diamond; R A Clark
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

9.  Interactions of human phagocytes with moulds Fusarium spp. and Verticillium nigrescens possessing different pathogenicity.

Authors:  Richard M Winn; Cristina Gil-Lamaignere; Avgi Maloukou; Emmanuel Roilides
Journal:  Med Mycol       Date:  2003-12       Impact factor: 4.076

10.  In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates.

Authors:  Joseph Meletiadis; Johan W Mouton; Jacques F G M Meis; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

View more
  4 in total

Review 1.  Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.

Authors:  Marisa Z R Gomes; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

2.  The initial 96 hours of invasive pulmonary aspergillosis: histopathology, comparative kinetics of galactomannan and (1->3) β-d-glucan and consequences of delayed antifungal therapy.

Authors:  William W Hope; Vidmantas Petraitis; Ruta Petraitiene; Tamarra Aghamolla; John Bacher; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2010-08-16       Impact factor: 5.191

Review 3.  The mucormycete-host interface.

Authors:  Ashraf S Ibrahim; Kerstin Voelz
Journal:  Curr Opin Microbiol       Date:  2017-11-04       Impact factor: 7.934

4.  A bacterial endosymbiont of the fungus Rhizopus microsporus drives phagocyte evasion and opportunistic virulence.

Authors:  Herbert Itabangi; Poppy C S Sephton-Clark; Diana P Tamayo; Xin Zhou; Georgina P Starling; Zamzam Mahamoud; Ignacio Insua; Mark Probert; Joao Correia; Patrick J Moynihan; Teclegiorgis Gebremariam; Yiyou Gu; Ashraf S Ibrahim; Gordon D Brown; Jason S King; Elizabeth R Ballou; Kerstin Voelz
Journal:  Curr Biol       Date:  2022-02-07       Impact factor: 10.834

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.